Caribou Biosciences, Inc. (CRBU) financial statements and ratios from SEC XBRL: revenue $11.16M (TTM), net margin -1327.4%, revenue growth 11.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $11.16M |
| Net Margin | -1327.4% |
| Revenue Growth (YoY) | 11.7% |
| EPS Growth (YoY) | -3.6% |
| FCF Growth (YoY) | -21.5% |
| Price / Book | 1.80 |
| Price / Sales | 20.83 |
| FCF Yield | -110.6% |
| Altman Z-Score | -4.87 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CRBU overview · CRBU earnings · CRBU KPIs · CRBU investor relations · CRBU ownership · CRBU peers · CRBU filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.